• Info
  • Insider Ownership

Insider Trading & Ownership of Christopher Rovaldi

Location
Cambridge, MA
Summary
The estimated net worth of Christopher Rovaldi is at least $2,640,600 dollars as of 19 Feb 2025. Christopher Rovaldi is the Chief Operating Officer of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $2.64M.
Signature
/s/ Keith Regnante, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Christopher Rovaldi files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Christopher Rovaldi

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KROS Keros Therapeutics, Inc. Chief Operating Officer $2,640,600 18 Feb 2025

Insider Transactions Reported by Christopher Rovaldi:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.